"Rate-Control Treatment and Mortality in Atrial Fibrillation"
"Conclusions—In this nationwide atrial fibrillation cohort, the risk of mortality was lower for patients receiving rate-control treatment with β-blockers or calcium channel blockers, and the use of β-blockers was associated with the largest risk reduction. Digoxin use was associated with greater mortality. Prospective, randomized trials are necessary to confirm these findings."
http://circ.ahajournals.org/content/132/17/1604.abstract
No comments:
Post a Comment